These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9054799)

  • 1. Contractures in neuroleptic malignant syndrome.
    Craddock B; Craddock N
    Am J Psychiatry; 1997 Mar; 154(3):436. PubMed ID: 9054799
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia.
    Black KJ; Racette B; Perlmutter JS
    Am J Psychiatry; 1998 Sep; 155(9):1298-9. PubMed ID: 9734560
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome].
    Silva HC; Bahia VS; Oliveira RA; Marchiori PE; Scaff M; Tsanaclis AM
    Arq Neuropsiquiatr; 2000 Sep; 58(3A):713-9. PubMed ID: 10973114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of neuroleptic malignant syndrome with electroconvulsive therapy.
    Lazarus A
    J Nerv Ment Dis; 1986 Jan; 174(1):47-9. PubMed ID: 3941310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome in Kufs' disease.
    Reif A; Schneider MF; Hoyer A; Schneider-Gold C; Fallgatter AJ; Roggendorf W; Pfuhlmann B
    J Neurol Neurosurg Psychiatry; 2003 Mar; 74(3):385-7. PubMed ID: 12588937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Catatonia and neuroleptic malignant syndrome in a mentally retarded patient].
    Heikkilä J; Raitasuo S; Lauerma H; Mölsä P
    Duodecim; 1992; 108(12):1120-4. PubMed ID: 1366062
    [No Abstract]   [Full Text] [Related]  

  • 7. A rapidly progressing lethal case of neuroleptic malignant syndrome.
    Lenler-Petersen P; Hansen BD; Hasselstrøm L
    Intensive Care Med; 1990; 16(4):267-8. PubMed ID: 2358561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome and hyperosmolar coma. Case report.
    Vongxaiburana MP
    W V Med J; 1988 Jul; 84(7):288-9. PubMed ID: 3407155
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders.
    Ebadi M; Srinivasan SK
    Pharmacol Rev; 1995 Dec; 47(4):575-604. PubMed ID: 8746555
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hyperthermia susceptibility in neuroleptic malignant syndrome.
    Caroff SN; Rosenberg H; Fletcher JE; Heiman-Patterson TD; Mann SC
    Anesthesiology; 1987 Jul; 67(1):20-5. PubMed ID: 3605730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catatonic and non-catatonic neuroleptic malignant syndrome.
    Lee JW
    Aust N Z J Psychiatry; 2000 Oct; 34(5):877-8. PubMed ID: 11037384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents?
    Lavie CJ; Olmsted TR; Ventura HO; Lepler BJ
    Postgrad Med; 1986 Sep; 80(3):171-8. PubMed ID: 2875454
    [No Abstract]   [Full Text] [Related]  

  • 14. The aftercare of the patient with the neuroleptic malignant syndrome.
    Aizenberg D; Shalev A; Munitz H
    Br J Psychiatry; 1985 Mar; 146():317-8. PubMed ID: 2985164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of neuroleptic malignant syndrome with myoglobinuric acute renal failure treated with dialysis and levodopa.
    Lambrecht ER; Meems BJ
    Neth J Med; 1987 Feb; 30(1-2):80-4. PubMed ID: 3587463
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome. Review of response to therapy.
    Rosenberg MR; Green M
    Arch Intern Med; 1989 Sep; 149(9):1927-31. PubMed ID: 2673115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of neuroleptic malignant syndrome and a hyperosmolar hyperglycemic state.
    Yang CW; Lu C; Wu CC; Wen SC
    Am J Emerg Med; 2012 Jun; 30(5):833.e1-2. PubMed ID: 21514763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperosmolar hyperglycemic state secondary to neuroleptic malignant syndrome.
    Takanobu K; Okazaki D; Ogawa T; Watanabe S; Oka M; Murakami S; Ura H
    Am J Emerg Med; 2015 Jan; 33(1):126.e1-2. PubMed ID: 25151326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis in neuroleptic malignant syndrome.
    Gaitini L; Fradis M; Vaida S; Krimerman S; Beny A
    Anaesthesia; 1997 Feb; 52(2):165-8. PubMed ID: 9059103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECT during and after the neuroleptic malignant syndrome: case report.
    Hughes JR
    J Clin Psychiatry; 1986 Jan; 47(1):42-3. PubMed ID: 3941060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.